View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 9, 2022

FX Solutions secures FDA 510k approval for FX V135 platform

The FX V135 platform features unique net-shape moulded humeral cups and 12 different baseplate options.

FX Solutions has received US Food and Drug Administration (FDA) 510k approval for its new FX V135 shoulder arthroplasty platform.

The FX V135 platform is a 70mm humeral stem, which is proximally coated with hydroxyapatite (HAP).

It features suture holes proximally for soft tissue repair as well as Titanium Nitride (TiN) coated and uncoated Cobalt Chrome (CoCr) humeral heads and glenospheres.

The platform also includes unique net-shape moulded humeral cups and 12 different baseplate options in the reverse construct.

It comprises a new-to-market mini stem humeral component that can be aligned at 135° for the reverse and anatomical configurations.

The company’s net-shape moulded humeral cups will allow surgeons to perform reverse construct using an asymmetric humeral cup to change the inclination to 145°.

FX Solutions CEO Baptiste Martin said: “The FX V135 was designed to allow surgeons to tailor our system to the patient – rather than the patient to our system.

“Across our portfolio, now, surgeons are able to lateralise or medialise on both the humeral and glenoid side of the procedure.

“The FX V135 has been long awaited, and we are eager to get this rolled out to the market and continue to grow our market share.”

The FX V135 anatomical configuration includes a taper component, which enables 360° of eccentricity.

This provides for a dual eccentricity offering between the humeral head components and taper.

FX stated that it is introducing the humeral head components with variable head heights to provide enhanced flexibility for surgeons to match the anatomy of patients.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network